Cart
sales@molnova.com
SB1317 hydrochloride
CAS No. ——
SB1317 hydrochloride( TG-02 hydrochloride )
Catalog No. M19398 CAS No. ——
SB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 70 | Get Quote |
|
| 5MG | 125 | Get Quote |
|
| 10MG | 206 | Get Quote |
|
| 25MG | 370 | Get Quote |
|
| 50MG | 451 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSB1317 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).
-
DescriptionSB1317 is an effective inhibitor of CDK2/JAK2/FLT3 (IC50: 13/73/56 nM).
-
In Vitro——
-
In Vivo——
-
SynonymsTG-02 hydrochloride
-
PathwayAngiogenesis
-
TargetCDK
-
RecptorCDK2| FLT3| JAK2
-
Research AreaCancer
-
IndicationAnaplastic astrocytoma; Glioblastoma
Chemical Information
-
CAS Number——
-
Formula Weight408.92
-
Molecular FormulaC23H25ClN4O
-
Purity>98% (HPLC)
-
SolubilityDMSO:26.5 mg/mL
-
SMILESCl.CN1C\C=C\CCOc2cccc(c2)-c2ccnc(Nc3cccc(C1)c3)n2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.William AD et al. Discovery of kinase spectrum selective macrocycle (16E)-14-methyl-20-oxa-571426-tetraazatetracyclo[19.3.1.1(26).1(812)]heptacosa-1(25)2(26)358(27)911162123-decaene (SB1317/TG02) a potent inhibitor of cyclin dependent kina.
molnova catalog
related products
-
SEL120-34A hydrochlo...
SEL120-34A is an ATP-competitive, selective, orally active CDK8 inhibitor that inhibits kinase activities of CDK8/CycC and CDK19/CycC complexes with IC50 of 4.4 nM and 10.4 nM, respectively.
-
ML365
ML365 is a novel selective small molecule inhibitor of TASK1(KCNK3).
-
LY2835219 mesylate
LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM in cell-free assays, respectively. Phase 3.
